j.restrepo

TL2 · Recife

Contributes reviews on supplier material. Based in Recife.

Joined 19 June 2025 · last posted 13d · groups: regional-apac

79 posts, newest first. Showing up to 150.

Tirzepatide storage and stability: what is published versus what is assumed Replied, post #18 · Compounds › Tirzepatide · 15 Jul 2026 · 0 likes Post #15 is right about the mechanism and I think understates the practical bit. Having read the whole tirzepatide storage and stability thread before replying: the…
What a certificate commits its issuer to Replied, post #18 · Analytics › COA interpretation · 12 Jul 2026 · 33 likes Coming back to post #14, because the follow-up matters more than the original answer. A certificate of analysis is a statement by its issuer that a defined test was…
Transit times by route, from a logged dataset Replied, post #3 · Sourcing › Logistics · 11 Jul 2026 · 22 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #20 · Evidence › Journal club · 3 Jul 2026 · 19 likes On SUSTAIN 6 the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Reading order for a first week here, and what to skip until later — what changed since Replied, post #9 · Start Here › Welcome · 3 Jul 2026 · 1 like Quietly grateful for the plain phrasing. Not every thread gets that.
What would change my mind about repair peptides: a specific answer Replied, post #16 · Compounds › Repair & healing peptides · 27 Jun 2026 · 0 likes Dose-response is unstudied in humans for essentially everything in this family, which means the confident numbers in circulation came from somewhere other than a trial.…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #85 · Evidence › Preprints · 21 Jun 2026 · 19 likes Post #84 is the version of this I will quote in future. One addition. Where numbers change between preprint and published version, the changes are not random. They tend…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #10 · Compounds › Retatrutide · 21 Jun 2026 · 0 likes I had written a reply contradicting post #8 and deleted it. Here is what survived. A theoretical mass for retatrutide is not published in the peer-reviewed literature…
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #31 · Analytics › Mass spectrometry · 20 Jun 2026 · 16 likes The reason 2 ppm match is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
Injecting into an area that has become firm: why not to Replied, post #92 · Practice › Administration · 17 Jun 2026 · 0 likes Post #88 and I disagree about the size of the effect, not about the direction. If you have to inject at a different time of day than usual, that is a much smaller…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #5 · Analytics › Impurities & related substances · 16 Jun 2026 · 0 likes Freeze-drying itself does not generate impurities in any significant way. Handling before and after it does, which is why transit conditions belong in the discussion.
Injecting into an area that has become firm: why not to Replied, post #77 · Practice › Administration · 15 Jun 2026 · 12 likes Avoid any area that is currently reacting, and avoid any area that has become firm or lumpy. That is not caution about comfort; tissue that has changed does not absorb…
Micronutrient adequacy at low total intake Replied, post #44 · Nutrition & Training › Protein & intake · 10 Jun 2026 · 2 likes The reason micronutrient adequacy keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
Reading a home test result without over-claiming Replied, post #73 · Analytics › Home & field testing · 9 Jun 2026 · 0 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
Fasting versus non-fasting and which tests care Replied, post #41 · Clinical › Bloodwork · 3 Jun 2026 · 12 likes Post #39 put the caveat in the right place and I want to underline it. Where the fasting versus non-fasting discussion usually stalls is that nobody wants to say "I do…
Angle of injection and whether 90 degrees is always right — the long version Replied, post #6 · Practice › Administration · 16 May 2026 · 24 likes Post #5 is right about the mechanism and I think understates the practical bit. If you have to inject at a different time of day than usual, that is a much smaller…
Second pass at: The storage lookup and where its data comes from Replied, post #17 · Data & Tools › Calculators · 14 May 2026 · 30 likes That reframing is the whole thing. The facts I already had.
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #42 · Start Here › Welcome · 17 Apr 2026 · 11 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #46 · Practice › Storage & stability · 13 Apr 2026 · 4 likes Where I part company with post #42, and it is a narrow parting. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation…
List price versus negotiated price versus what you pay Replied, post #58 · Access › Pricing · 13 Apr 2026 · 9 likes This follows post #55 rather than contradicting it. On list price versus negotiated price I would separate what is worth knowing from what is worth acting on. The first…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #9 · Safety › Contraindications · 12 Apr 2026 · 30 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either.
Reflux appearing for the first time at a dose step Started this topic · Practice › Side effects · 6 Apr 2026 · 1 like Reflux appearing for the first time at a dose step — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about…
Journal club: LEADER as the historical anchor Replied, post #53 · Evidence › Journal club · 30 Mar 2026 · 21 likes Worth stating the null on LEADER before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
[2026 update] What a purity-only report leaves out Replied, post #70 · Sourcing › Independent verification · 29 Mar 2026 · 32 likes The version of purity-only that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Forced degradation studies: designing one that is informative Replied, post #26 · Analytics › Method validation · 26 Mar 2026 · 18 likes Post #25 describes the usual case. This is about the unusual one. Range and working range are different things and a certificate rarely distinguishes them. The relevant…
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #81 · Sourcing › Vendor reports · 14 Mar 2026 · 1 like On post #77 — agreed on the reasoning, with one qualification. Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the…
Reconstitution volumes that produce round numbers, tabulated Replied, post #61 · Practice › Reconstitution · 7 Mar 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Type 2 diabetes and the largest part of the evidence base Replied, post #23 · Clinical › Comorbidities · 7 Mar 2026 · 2 likes A condition that affects nutrition or absorption changes the calculus around a treatment that reduces intake, and that interaction is mostly unstudied. The part I am…
Second pass at: Fasting versus non-fasting and which tests care Replied, post #16 · Clinical › Bloodwork · 28 Feb 2026 · 0 likes Adding the measurement that post #14 says would settle it. Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is…
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Replied, post #8 · Data & Tools › Datasets · 26 Feb 2026 · 3 likes Self-reported, unblinded, self-selected data has known biases and is still worth collecting, provided every one of those words appears in the description.
A widely repeated interaction claim that turns out to be unsupported Replied, post #31 · Practice › Interactions · 26 Feb 2026 · 7 likes I had written a reply contradicting post #29 and deleted it. Here is what survived. The documentation on widely repeated interaction claim is better than this thread…
Measurement error in a self-reported exposure Replied, post #10 · Evidence › Study critique · 22 Feb 2026 · 33 likes Post #6 put the caveat in the right place and I want to underline it. Measurement error is worth one more sentence than it usually gets, and the sentence is the one…
Run-in periods and the population they select Replied, post #67 · Evidence › Trials · 16 Feb 2026 · 0 likes Entry criteria, run-in periods and the self-selection of people willing to enter a multi-year trial all narrow the population. That is how internal validity is bought…
Cold solution and stinging: the simplest fix Replied, post #2 · Practice › Administration · 15 Feb 2026 · 0 likes Worth separating two things that the opening post runs together. Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #39 · Analytics › Impurities & related substances · 15 Feb 2026 · 2 likes Where the rising related-substance reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Citation sweep results: how many references did not say what was claimed Replied, post #45 · Meta › Wiki maintenance · 13 Feb 2026 · 30 likes Genuine question rather than a rhetorical one: has anyone here actually observed citation sweep results, as opposed to read about it? The thread is long and I cannot…
Temperature loggers worth the money — the long version Replied, post #126 · Devices › Cold chain · 3 Feb 2026 · 26 likes Building on post #125 rather than restating it. Temperature loggers worth the money is one of those subjects where the general answer and the answer for a specific case…
Pharmacy supply in the UK and the questions you will be asked Replied, post #27 · Regional › UK & Ireland · 1 Feb 2026 · 25 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
Lyophilisation and why the cake looks the way it does Replied, post #37 · Pharmacology › Formulation chemistry · 31 Jan 2026 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
What a good consultation looks like from the other side Replied, post #13 · Clinical › Prescriber conversations · 30 Jan 2026 · 25 likes On post #9 — agreed on the reasoning, with one qualification. Written summaries after an appointment are available in many systems and are worth asking for, because…
Can a home kit substitute for a laboratory report? A careful no Replied, post #118 · Analytics › Home & field testing · 27 Jan 2026 · 32 likes Where home testing is genuinely valuable is as a screen before spending on independent analysis, not as a substitute for it. One of those cases where knowing the…
A history of disordered eating: proceeding carefully Replied, post #35 · Wellbeing › Mental health · 21 Dec 2025 · 8 likes The number people quote for history of disordered eating is a central estimate presented without its interval, and the interval is wide enough that the estimate is…
The decimal-point error, and the habit that catches it Replied, post #57 · Practice › Reconstitution · 16 Dec 2025 · 31 likes What I would want before treating decimal-point error as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are…
Why oral semaglutide needs an absorption enhancer at all — one year on Replied, post #4 · Compounds › Oral incretins · 10 Dec 2025 · 12 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
Tracking a preprint to publication: a worked example Replied, post #69 · Evidence › Preprints · 7 Dec 2025 · 0 likes A preprint reporting a null result is more likely to stay a preprint, which biases the published literature and makes preprint servers more valuable rather than less.…
Revisiting: German, French and Dutch differences, compared Replied, post #99 · Regional › European Union · 9 Nov 2025 · 11 likes Correcting a stale claim here is more valuable than adding a new one, because the stale claims are what people find first. This is the sort of thing the wiki should…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #2 · Practice › Interactions · 26 Oct 2025 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. Anyone asking an interaction question should list everything, including the…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #119 · Compounds › Tirzepatide · 24 Oct 2025 · 0 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
Power cut for eleven hours: how I assessed it afterwards Replied, post #76 · Practice › Storage & stability · 29 Sep 2025 · 2 likes Building on post #75 rather than restating it. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption…
Temperature loggers worth the money — the long version Replied, post #36 · Devices › Cold chain · 6 Sep 2025 · 10 likes Temperature loggers worth the money has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #75 · Practice › Side effects · 6 Sep 2025 · 0 likes Picking up post #72: that is the part I would want checked first. The bit of Fatigue that nobody enjoys is that the answer changes depending on what you are trying to…
Are there stupid questions here? A staff answer, at length Replied, post #140 · Start Here › Welcome · 1 Sep 2025 · 28 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
DXA precision and the least significant change for lean mass — what changed since Replied, post #2 · Outcomes › Body composition · 15 Aug 2025 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #20 · Start Here › Welcome · 1 Aug 2025 · 0 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
A field-by-field walk through a certificate of analysis Replied, post #14 · Analytics › COA interpretation · 14 Jul 2025 · 0 likes Picking up post #13: that is the part I would want checked first. A methods point on field-by-field walk through a certificate rather than a substantive one: if the…
Asking about a compound your prescriber has not heard of Replied, post #87 · Clinical › Prescriber conversations · 7 Jul 2025 · 8 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #64 · Sourcing › Independent verification · 17 Jun 2025 · 31 likes That is a cleaner way of putting what I was circling around.
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #58 · Compounds › Retatrutide · 31 May 2025 · 6 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #86 · Practice › Interactions · 15 May 2025 · 1 like Sensible. I would want the same detail before I acted on it either.
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #58 · Devices › Syringes & needles · 22 Apr 2025 · 6 likes A definition problem is doing most of the work in this Gauge and length selection discussion. Once the term is pinned down I suspect the disagreement mostly goes away…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #60 · Compounds › Tirzepatide · 13 Apr 2025 · 0 likes I had written a reply contradicting post #59 and deleted it. Here is what survived. SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was…
Certificates issued by the seller versus by a laboratory Replied, post #25 · Analytics › COA interpretation · 31 Mar 2025 · 32 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #17 · Meta › Wiki maintenance · 19 Mar 2025 · 0 likes Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs it is mid-task and will not follow a link. The test is…
Charge states for a 4 kDa peptide, worked through Replied, post #28 · Analytics › Mass spectrometry · 5 Mar 2025 · 0 likes My experience of charge states contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #15 · Compounds › Tirzepatide · 18 Feb 2025 · 5 likes The arithmetic in post #12 is right; the assumption feeding it is the part to check. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on…
Oxidation and deamidation mass shifts, tabulated Replied, post #55 · Analytics › Mass spectrometry · 16 Feb 2025 · 32 likes Tandem mass spectrometry with fragmentation gives sequence information that intact mass cannot. It is the analysis that would actually confirm identity, and it is…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #8 · Compounds › Secretagogues & GH axis · 8 Feb 2025 · 32 likes My position on Tesamorelin is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Distinguishing a deletion sequence by mass alone Replied, post #58 · Analytics › Mass spectrometry · 7 Feb 2025 · 0 likes Coming back to post #56, because the follow-up matters more than the original answer. What mass accuracy establishes: the measured mass is consistent with a specific…
Foaming during reconstitution and whether it matters Replied, post #3 · Practice › Reconstitution · 3 Feb 2025 · 0 likes The bit of foaming during reconstitution that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and…
Second pass at: A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #11 · Devices › Pens & autoinjectors · 23 Jan 2025 · 2 likes Narrowing post #8, because the general version has more than one answer. A pen that will not dial to the intended dose is usually telling you the cartridge does not…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #10 · Evidence › Journal club · 16 Oct 2024 · 22 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
A newcomer's list of things that confused me, and the fixes Started this topic · Start Here › Welcome · 14 Oct 2024 · 7 likes A newcomer's list of things that confused me, and the fixes — setting out what I have, and where I think it stops being reliable. Question in the title. Context below,…
Progressive overload when the scale is falling — one year on Replied, post #157 · Nutrition & Training › Resistance training · 13 Oct 2024 · 0 likes Anybody returning after a break should expect to start lower than they left, and expecting otherwise is where injuries come from. Happy to expand any of that if it is…
About the Off topic category Replied, post #5 · Lounge › Off topic · 12 Oct 2024 · 10 likes Not a rules-free zone: the guidelines still apply. No contact details, no invitations to take a conversation off the site, no endorsements of other communities. Just a…
Coming back to: Renal impairment: what the labelling says about dose Replied, post #4 · Clinical › Special populations · 16 Sep 2024 · 7 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
Taste changes and food aversion, reported and discussed Replied, post #18 · Practice › Side effects · 11 Sep 2024 · 28 likes Following this. I have the same question and no better information than the first post.
Progressive overload when the scale is falling — one year on Replied, post #36 · Nutrition & Training › Resistance training · 8 Sep 2024 · 23 likes Worth separating two things that post #34 runs together. My experience of Progressive overload contradicts the reply above. I am posting it as a data point rather than…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #51 · Practice › Dosing & titration · 25 Aug 2024 · 7 likes Post #50 answers the question as asked. The question underneath it is different. Concentration and dose get conflated constantly in this subcategory. Changing how much…
Correlation in a self-tracked dataset: what it can support Replied, post #19 · Research Methods › Statistics · 20 Aug 2024 · 0 likes Counterpoint on correlation, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.